Evidence map›Paper›PMID 39044082›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2024

Detection and Quantification of HBV Transcripts by Full-Length 5'RACE-PCR.

Guillaume Giraud, Doohyun Kim, Bernd Stadelmayer, Fleur Chapus, Barbara Testoni, Fabien Zoulim

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Guillaume GiraudCancer Research Center of Lyon (CRCL), UMR Inserm 1052 CNRS 5286 Mixte, CLB, Université de Lyon 1 (UCBL1), Lyon, France.
Doohyun KimCancer Research Center of Lyon (CRCL), UMR Inserm 1052 CNRS 5286 Mixte, CLB, Université de Lyon 1 (UCBL1), Lyon, France.
Bernd StadelmayerCancer Research Center of Lyon (CRCL), UMR Inserm 1052 CNRS 5286 Mixte, CLB, Université de Lyon 1 (UCBL1), Lyon, France.
Fleur ChapusCancer Research Center of Lyon (CRCL), UMR Inserm 1052 CNRS 5286 Mixte, CLB, Université de Lyon 1 (UCBL1), Lyon, France.
Barbara TestoniCancer Research Center of Lyon (CRCL), UMR Inserm 1052 CNRS 5286 Mixte, CLB, Université de Lyon 1 (UCBL1), Lyon, France. barbara.testoni@inserm.fr.
Fabien ZoulimCancer Research Center of Lyon (CRCL), UMR Inserm 1052 CNRS 5286 Mixte, CLB, Université de Lyon 1 (UCBL1), Lyon, France. fabien.zoulim@inserm.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic hepatitis B virus infection is a major health burden worldwide. Although efficient in maintaining the infection under control, current treatments are unable to fully eradicate the virus due to the persistence of its minichromosome, the so-called cccDNA. In the context of emerging antiviral and combinatorial therapies aiming at decreasing the cccDNA pool or at silencing its transcriptional activity, the detection and quantification of viral RNAs have gained increasing interest as a way to monitor the HBV reservoir. Here, we describe the protocol of the HBV full-length 5'RACE, a technique that allows to define the repertoire of the different HBV RNA species in vitro, intracellularly and extracellularly, and in vivo, in patients' serum in a qualitative or quantitative manner, depending on the choice of the post-analysis methodology.

Indexed as

Hepatitis B virusRNA, ViralHepatitis B, ChronicHumansPolymerase Chain ReactionRNA, Viral5′RACEHBVHBV RNAs

Identifiers

PMID39044082

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.